CSL share price: why investors like healthcare shares

The CSL Ltd (ASX:CSL) share price is down 24.3% since the start of 2025. Is it time that you added CSL shares to your watchlist?

CSL share price in focus

CSL is a global biotechnology company that creates and delivers life-saving medicines, aiming to protect public health and improve the quality of life for those with life-threatening conditions.

The company operates through three main divisions: CSL Behring, CSL Seqirus, and CSL Vifor. Behring, acquired in 2004, focuses on manufacturing and distributing blood plasma products. Seqirus, formed from the rebranding of BioCSL and the acquisition of Novartis’ flu business in 2015, develops flu-related products and provides pandemic-related services to governments. Vifor specializes in…